A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was t...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2019-07-01
|
Series: | Journal of Family and Reproductive Health |
Subjects: | |
Online Access: | https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049 |
_version_ | 1818891017786490880 |
---|---|
author | Majid Mokhtari Khadijeh Nasri Fatemeh Tara Elahe Zarean Sedigheh Hantoushzadeh Mehrnaz Radmehr Maryam Kashanian |
author_facet | Majid Mokhtari Khadijeh Nasri Fatemeh Tara Elahe Zarean Sedigheh Hantoushzadeh Mehrnaz Radmehr Maryam Kashanian |
author_sort | Majid Mokhtari |
collection | DOAJ |
description | Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran.
Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis.
Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis. |
first_indexed | 2024-12-19T17:34:07Z |
format | Article |
id | doaj.art-1daf299c81e3406a886d3cc93e6546c1 |
institution | Directory Open Access Journal |
issn | 1735-8949 1735-9392 |
language | English |
last_indexed | 2024-12-19T17:34:07Z |
publishDate | 2019-07-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | Journal of Family and Reproductive Health |
spelling | doaj.art-1daf299c81e3406a886d3cc93e6546c12022-12-21T20:12:22ZengTehran University of Medical SciencesJournal of Family and Reproductive Health1735-89491735-93922019-07-0113110.18502/jfrh.v13i1.16091049A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in IranMajid Mokhtari0Khadijeh Nasri1Fatemeh Tara2Elahe Zarean3Sedigheh Hantoushzadeh4Mehrnaz Radmehr5Maryam Kashanian6Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Imam Hosein Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Arak University of Medical Sciences, Arak, IranDepartment of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Ommol Banin Teaching Hospital, Mashhad, IranDepartment of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Alzahra Teaching Hospital, Isfahan, IranMaternal-Fetal Medicine Research Center, Tehran University of Medical Sciences, Imam Khomeini Teaching Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Milad Hospital, Tehran, IranDepartment of Obstetrics and Gynecology, Iran University of Medical Sciences, Akbarabadi Teaching Hospital, Tehran, IranObjective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis.https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049Venous Thrombo-embolismObstetric PopulationDeep Venous ThrombosisVTE ProphylaxisPulmonary Embolism |
spellingShingle | Majid Mokhtari Khadijeh Nasri Fatemeh Tara Elahe Zarean Sedigheh Hantoushzadeh Mehrnaz Radmehr Maryam Kashanian A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran Journal of Family and Reproductive Health Venous Thrombo-embolism Obstetric Population Deep Venous Thrombosis VTE Prophylaxis Pulmonary Embolism |
title | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_full | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_fullStr | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_full_unstemmed | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_short | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_sort | survey of venous thromboembolism vte prophylaxis in obstetrics patients in iran |
topic | Venous Thrombo-embolism Obstetric Population Deep Venous Thrombosis VTE Prophylaxis Pulmonary Embolism |
url | https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1049 |
work_keys_str_mv | AT majidmokhtari asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT khadijehnasri asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT fatemehtara asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT elahezarean asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT sedighehhantoushzadeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT mehrnazradmehr asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT maryamkashanian asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT majidmokhtari surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT khadijehnasri surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT fatemehtara surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT elahezarean surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT sedighehhantoushzadeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT mehrnazradmehr surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT maryamkashanian surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran |